RXMD Absolutely this is so undervalued it's screaming BUY BUY BUY... Investors and big money managers around the world agree that once you hit 10 million in revenue per year you're fair game for M&A. At 22 million potentially this year for RXMD, they must be getting a ton of offers. The wait will be well worth it and many will be amazed at how fast it happens. This is like being able to buy a McLaren sports car for $10,000...